Long-term outcomes of childhood-onset systemic lupus erythematosus

Archive ouverte

Mirguet, Anne | Aeschlimann, Florence | Lemelle, Irène | Jaussaud, Roland | Decker, Paul | Moulinet, Thomas | Mohamed, Shirine | Quartier, Pierre | Hofer, Michael | Boyer, Olivia | Belot, Alexandre | Hummel, Aurélie | Costedoat-Chalumeau, Nathalie | Bader-Meunier, Brigitte

Edité par CCSD ; Oxford University Press (OUP) -

International audience. Abstract Objective Data on the long-term outcome of patients with childhood-onset SLE (cSLE) are scarce. Aims of this study were to describe the long-term outcomes of cSLE and to identify factors associated with the development of damage and persistent disease activity. Methods We conducted a retrospective multicentre study using data from the PEDIALUP registry of the Juvenile Inflammatory Rheumatism (JIR) cohort database. Demographic characteristics, clinical manifestations, laboratory, radiological, histological and treatment data were collected from medical records during follow-up. Results A total of 138 patients with cSLE, diagnosed between 1971 and 2015, were included. With a median follow-up of 15.4 [9.6–22.4] years, 51% of patients had a SLICC-damage index (DI) score ≥1 at last follow-up with the musculoskeletal, cutaneous, renal, neurological and cardiovascular damage being the most common manifestations. The proportion of patients with a SLICC-DI score ≥1 increased significantly with the duration of the follow-up (P < 0.001). On multivariate analysis, duration of follow-up was associated with increased risk of cumulative damage (OR 1.08, 95% CI 1.01, 1.15, P = 0.035). At the last visit, 34% of patients still had active disease with a SLEDAI score of ≥6. On multivariate analysis, sub-Saharan African ethnicity was associated with 7-fold increased odds of having active disease at the last visit compared with Caucasians (OR 7.44, 95% CI 2.24, 24.74, P = 0.0002). Conclusion The prevalence of damage remains high in patients with cSLE even when the diagnosis of cSLE has been made in the recent decades.

Consulter en ligne

Suggestions

Du même auteur

The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France

Archive ouverte | Moulis, Guillaume | CCSD

International audience

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus

Archive ouverte | Kleinmann, Jean-François | CCSD

International audience. Background/purpose: Despite conventional immunosuppressants, active and steroid-dependent systemic lupus erythematosus (SLE) represents a therapeutic challenge. Only one biologic, belimumab, ...

Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis

Archive ouverte | Bader-Meunier, Brigitte | CCSD

International audience. Objective: To investigate the relationship of clinical response of Juvenile Idiopathic Arthritis (JIA) to etanercept (ETN) with ETN levels, and the presence of anti-drug antibodies to ETN (AD...

Chargement des enrichissements...